-
Citigroup Maintains Neutral, $78 Target on Mead Johnson
Tuesday, December 27, 2011 - 11:15am | 133Read More...Citigroup reiterates its Neutral rating and $78 target price on Mead Johnson (NYSE: MJN) as it evaluates the situation following infant formula issues and the link with baby death. Citigroup notes, "On Christmas Day (12/25), Mead Johnson issued a statement which indicated that newly run tests on...
-
Is The Government Too Busy Whining About Debt To Protect Us From Death?
Wednesday, August 3, 2011 - 9:06am | 376Read More...While they whined about the “debt crisis,” 76 people were sickened and one person died. The news came out of nowhere. With “debt ceiling” nonsense and “we can't agree” hyperbole ruling the airwaves, the Internet, and all other forms of news distribution, few people were aware of our nation's...
-
HIV Treatment Also Beneficial to Preventing Infection
Thursday, May 12, 2011 - 1:10pm | 289Read More...The primary treatment for HIV infection — antiretroviral drugs — shows promise not just for treating patients with HIV, but also in preventing the spread of HIV to uninfected partners. In a landmark study, researchers found that treating infected patients with antiretroviral drugs prevented...

